Welcome to our dedicated page for Amerant Bancorp SEC filings (Ticker: AMTB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Amerant Bancorp Inc. (AMTB) doesn鈥檛 just run neighborhood branches; its filings map a lending book that spans Miami coastal real estate, Houston energy suppliers, and high-net-worth wealth management accounts. Understanding how shifting deposit costs or a single commercial loan charge-off flows through the balance sheet can be daunting. That鈥檚 why investors search for 鈥淎merant Bancorp SEC filings explained simply鈥� instead of combing through footnotes.
Stock Titan鈥檚 AI turns every disclosure into clarity. Need the Amerant Bancorp annual report 10-K simplified? We highlight net-interest margin drivers and credit-quality trends in seconds. Curious about Amerant Bancorp insider trading Form 4 transactions? AG真人官方-time alerts surface each executive stock move, so you can track Amerant Bancorp Form 4 insider transactions real-time without scouring EDGAR. Our platform also breaks down the Amerant Bancorp quarterly earnings report 10-Q filing into margin, loan-growth, and deposit-mix snapshots, while concise bullet summaries explain every 8-K material event, from branch sales to leadership changes.
Here鈥檚 what you鈥檒l find on this page:
- Instant AI summaries of 10-K, 10-Q, and 8-K forms鈥攏o jargon, just insights
- One-click access to Amerant Bancorp executive stock transactions Form 4
- Contextual notes that tie allowance for credit losses to specific loan portfolios
- Proxy statement coverage revealing Amerant Bancorp proxy statement executive compensation details
- Downloadable spreadsheets for deeper Amerant Bancorp earnings report filing analysis
Whether you鈥檙e modeling liquidity ratios, monitoring Amerant Bancorp 8-K material events explained, or simply understanding Amerant Bancorp SEC documents with AI, this page delivers every filing the moment it hits EDGAR鈥攁lready distilled into the numbers and narratives that move the stock.
CCC Intelligent Solutions Holdings (CCCS) 鈥� Form 4 (07/30/2025)
CEO & Chairman Githesh Ramamurthy reported two same-day transactions:
- 600,000 shares acquired via RSU vesting (Code M) at a $0 exercise price.
- 265,800 shares sold (Code F) at $9.78 per share, generating 鈮�$2.6 million (likely tax withholding).
After the activity, direct holdings total 7,820,231 shares, up ~4.5 % net versus pre-transaction levels; indirect holdings remain 13,628,362 shares through Higginson Enterprises LLC. No derivative securities remain outstanding from this RSU grant.
In aggregate, Ramamurthy controls 鈮�21.4 million shares, signaling continued long-term exposure despite the partial sale. Investors may view the net share increase as modestly supportive of management鈥檚 confidence, while recognizing that insider sales can add short-term supply.
Amerant Bancorp Inc. (AMTB) 鈥� Form 4 Insider Activity
On 28 Jul 2025, director Jack L. Kopnisky purchased 5,000 Class A common shares in the open market (transaction code P) at $20.21 per share, a total outlay of roughly $101k. After the trade he now directly owns 5,000 shares. No derivative securities or additional transactions were reported and no other officers joined the filing.
- This is the first holding disclosed for Kopnisky, filed individually.
- Purchase represents a modest stake relative to AMTB鈥檚 share count but signals personal confidence.
ALT5 Sigma Corporation (NASDAQ: ALTS) filed an 8-K announcing the May 9 2025 acquisition of 鈥淢swipe,鈥� a Canada-based provider of multi-currency, fiat- and crypto-enabled payment card solutions available on Visa and Mastercard networks.
- Strategic rationale: Mswipe鈥檚 B2B platform extends ALT5鈥檚 existing digital-asset settlement offering by adding globally usable physical & virtual cards, real-time FX/crypto conversion and robust compliance.
- Consideration: (i) 1 million restricted ALTS shares valued at $6.10 each (~$6.1 M); (ii) 500 k four-year warrants exercisable at $5.50; (iii) $4.8 M in shares of spin-off Alyea Therapeutics; (iv) two 14-month promissory notes totalling ~$1 M at 3.99% interest; and (v) assumption/reset of an existing $5.1 M target-level note.
- Contingent payout: Sellers may receive a one-time earn-out of up to $20 M (cash or stock) if the operating subsidiaries reach 鈮�$15 M annualised or actual revenue.
- Audited FY25/FY24 Mswipe financials (Ex. 99.1) and unaudited pro-forma combined statements (Ex. 99.2) were filed; a press release (Ex. 99.3) was issued on May 13 2025.
No immediate revenue or EPS guidance was provided. The transaction is expected to close seamlessly as ALT5 integrates card issuance, aiming to bridge digital assets with traditional payment rails.
On June 24, 2025, Amerant Bancorp Inc. (NYSE: AMTB) filed a Form 8-K reporting governance changes under Item 5.02. The Board of Directors unanimously voted to increase its size from ten to twelve members and, effective the same day, appointed Patricia (鈥淧atty鈥�) Morrison and Jack Kopnisky as non-employee directors of both the holding company and its wholly owned subsidiary, Amerant Bank, N.A. The appointments were recommended by the Corporate Governance, Nominating and Sustainability Committee and each director will serve until the 2026 Annual Meeting, unless earlier resignation or removal.
The filing states that no committee assignments have yet been determined and that neither appointee has related-party transactions reportable under Item 404(a) of Regulation S-K. Compensation will consist of a pro-rated portion of the US$46,000 annual cash retainer for Board service in 2025, additional cash retainers if committee roles are subsequently assigned, and the standard annual equity grant of restricted stock units awarded to all non-employee directors. Item 8.01 also references a press release (Exhibit 99.1) announcing the appointments. No financial metrics, operational updates, or other material events were disclosed in this filing.